FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3186087978> ?p ?o ?g. }

• W3186087978 endingPage "2601" @default.
• W3186087978 startingPage "2593" @default.
• W3186087978 abstract "This study aims to explore the effect of the ITI (interferon alpha-1b, thalidomide, and interleukin-2) regimen on the AML1-ETO fusion gene in patients with t(8;21) acute myeloid leukemia (AML) who were in hematologic remission but positive for the AML1-ETO fusion gene. From September 2014 to November 2020; 20 patients with AML (15 from The Affiliated Cancer Hospital of Zhengzhou University, 4 from The First Affiliated Hospital; and College of Clinical Medicine of Henan University of Science and Technology, and 1 from Anyang District Hospital) with hematological remission but AML1-ETO fusion gene positivity were treated with different doses of the ITI regimen to monitor changes in AML1-ETO fusion gene levels. Twenty patients were treated with a routine dose of the ITI regimen, including 13 males and 7 females. The median patient age was 38 (14-70 years). The fusion gene was negative in 10 patients after 1 (0.5 ~ 8.6) month, significantly decreased in 4 patients after 2.8 (1 ~ 6) months, increased in 4 patients, and unchanged in 2 patients. The 4 patients with elevated levels of the fusion gene were treated with an increased dose of the ITI regimen, and all four patients became negative, for a total effective rate of 90%. The ITI regimen reduces AML1-ETO fusion gene levels in patients with AML who are in hematologic remission but are fusion gene-positive. Improvement was observed in patients' response to a higher dose administration, and patients tolerated the treatment well." @default.
• W3186087978 created "2021-08-02" @default.
• W3186087978 creator A5039098958 @default.
• W3186087978 creator A5052368006 @default.
• W3186087978 creator A5057117256 @default.
• W3186087978 creator A5066054740 @default.
• W3186087978 creator A5070295178 @default.
• W3186087978 creator A5079986134 @default.
• W3186087978 creator A5086664284 @default.
• W3186087978 date "2021-07-27" @default.
• W3186087978 modified "2023-10-14" @default.
• W3186087978 title "Combined use of interferon alpha-1b, interleukin-2, and thalidomide to reverse the AML1-ETO fusion gene in acute myeloid leukemia" @default.
• W3186087978 cites W1963777403 @default.
• W3186087978 cites W1971455987 @default.
• W3186087978 cites W1984658294 @default.
• W3186087978 cites W1992419693 @default.
• W3186087978 cites W2026826794 @default.
• W3186087978 cites W2047011631 @default.
• W3186087978 cites W2097192169 @default.
• W3186087978 cites W2109005340 @default.
• W3186087978 cites W2127568389 @default.
• W3186087978 cites W2153994826 @default.
• W3186087978 cites W2161938647 @default.
• W3186087978 cites W2417694294 @default.
• W3186087978 cites W2559537906 @default.
• W3186087978 cites W2783450169 @default.
• W3186087978 cites W3025456392 @default.
• W3186087978 cites W4237098503 @default.
• W3186087978 cites W4287025205 @default.
• W3186087978 doi "https://doi.org/10.1007/s00277-021-04621-w" @default.
• W3186087978 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8440286" @default.
• W3186087978 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34312685" @default.
• W3186087978 hasPublicationYear "2021" @default.
• W3186087978 type Work @default.
• W3186087978 sameAs 3186087978 @default.
• W3186087978 citedByCount "3" @default.
• W3186087978 countsByYear W31860879782022 @default.
• W3186087978 countsByYear W31860879782023 @default.
• W3186087978 crossrefType "journal-article" @default.
• W3186087978 hasAuthorship W3186087978A5039098958 @default.
• W3186087978 hasAuthorship W3186087978A5052368006 @default.
• W3186087978 hasAuthorship W3186087978A5057117256 @default.
• W3186087978 hasAuthorship W3186087978A5066054740 @default.
• W3186087978 hasAuthorship W3186087978A5070295178 @default.
• W3186087978 hasAuthorship W3186087978A5079986134 @default.
• W3186087978 hasAuthorship W3186087978A5086664284 @default.
• W3186087978 hasBestOaLocation W31860879781 @default.
• W3186087978 hasConcept C104317684 @default.
• W3186087978 hasConcept C111829193 @default.
• W3186087978 hasConcept C126322002 @default.
• W3186087978 hasConcept C143998085 @default.
• W3186087978 hasConcept C194409129 @default.
• W3186087978 hasConcept C203014093 @default.
• W3186087978 hasConcept C2776178377 @default.
• W3186087978 hasConcept C2776364478 @default.
• W3186087978 hasConcept C2778461978 @default.
• W3186087978 hasConcept C2778729363 @default.
• W3186087978 hasConcept C2779609412 @default.
• W3186087978 hasConcept C2781413609 @default.
• W3186087978 hasConcept C2909179924 @default.
• W3186087978 hasConcept C55493867 @default.
• W3186087978 hasConcept C71924100 @default.
• W3186087978 hasConcept C86803240 @default.
• W3186087978 hasConcept C90924648 @default.
• W3186087978 hasConceptScore W3186087978C104317684 @default.
• W3186087978 hasConceptScore W3186087978C111829193 @default.
• W3186087978 hasConceptScore W3186087978C126322002 @default.
• W3186087978 hasConceptScore W3186087978C143998085 @default.
• W3186087978 hasConceptScore W3186087978C194409129 @default.
• W3186087978 hasConceptScore W3186087978C203014093 @default.
• W3186087978 hasConceptScore W3186087978C2776178377 @default.
• W3186087978 hasConceptScore W3186087978C2776364478 @default.
• W3186087978 hasConceptScore W3186087978C2778461978 @default.
• W3186087978 hasConceptScore W3186087978C2778729363 @default.
• W3186087978 hasConceptScore W3186087978C2779609412 @default.
• W3186087978 hasConceptScore W3186087978C2781413609 @default.
• W3186087978 hasConceptScore W3186087978C2909179924 @default.
• W3186087978 hasConceptScore W3186087978C55493867 @default.
• W3186087978 hasConceptScore W3186087978C71924100 @default.
• W3186087978 hasConceptScore W3186087978C86803240 @default.
• W3186087978 hasConceptScore W3186087978C90924648 @default.
• W3186087978 hasIssue "10" @default.
• W3186087978 hasLocation W31860879781 @default.
• W3186087978 hasLocation W31860879782 @default.
• W3186087978 hasLocation W31860879783 @default.
• W3186087978 hasLocation W31860879784 @default.
• W3186087978 hasOpenAccess W3186087978 @default.
• W3186087978 hasPrimaryLocation W31860879781 @default.
• W3186087978 hasRelatedWork W2013163224 @default.
• W3186087978 hasRelatedWork W2085326265 @default.
• W3186087978 hasRelatedWork W2280033251 @default.
• W3186087978 hasRelatedWork W2371783991 @default.
• W3186087978 hasRelatedWork W2373159162 @default.
• W3186087978 hasRelatedWork W2584383839 @default.
• W3186087978 hasRelatedWork W2800159896 @default.
• W3186087978 hasRelatedWork W3012729910 @default.
• W3186087978 hasRelatedWork W3029628974 @default.
• W3186087978 hasRelatedWork W3186087978 @default.

• next